Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.95B P/E 10.47 EPS this Y 5.20% Ern Qtrly Grth -66.20%
Income 114.99M Forward P/E 9.90 EPS next Y 66.50% 50D Avg Chg -8.00%
Sales 656.11M PEG 0.79 EPS past 5Y 14.97% 200D Avg Chg -26.00%
Dividend N/A Price/Book 4.03 EPS next 5Y 22.60% 52W High Chg -48.00%
Recommedations 2.40 Quick Ratio 2.93 Shares Outstanding 56.83M 52W Low Chg 9.00%
Insider Own 19.75% ROA 13.75% Shares Float 34.68M Beta 0.73
Inst Own 93.64% ROE 22.47% Shares Shorted/Prior 8.41M/8.73M Price 32.56
Gross Margin 79.41% Profit Margin 17.53% Avg. Volume 465,361 Target Price 43.29
Oper. Margin 12.36% Earnings Date Oct 29 Volume 863,927 Change -4.21%
About Harmony Biosciences Holdings, I

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Harmony Biosciences Holdings, I News
11/05/24 There May Be Some Bright Spots In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings
11/01/24 Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
11/01/24 Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
10/31/24 HRMY vs. REGN: Which Stock Is the Better Value Option?
10/31/24 Harmony Biosciences Holdings Third Quarter 2024 Earnings: Beats Expectations
10/30/24 Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders
10/30/24 Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...
10/30/24 Q3 2024 Harmony Biosciences Holdings Inc Earnings Call
10/29/24 Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders
10/29/24 Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat
10/29/24 Harmony Biosciences (HRMY) Q3 2024 Earnings Call Transcript
10/29/24 Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Surpass Estimates
10/29/24 HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS
10/23/24 Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for
10/22/24 Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: Should You Buy?
10/16/24 HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024
10/14/24 Wall Street Analysts Favor Harmony Biosciences Holdings, Inc. (HRMY) for Growth
10/11/24 Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) The Top Stock With Improving Technical Ratings According To Piper Sandler?
10/09/24 Harmony Biosciences Holdings Inc (HRMY) Q2 2024 Earnings Call Highlights: Strong Revenue Growth ...
10/03/24 Mizuho adds 2 new stocks to its Top Picks list
HRMY Chatroom

User Image UncleStock Posted - 19 hours ago

$SIGA $HRMY $INVA $EXEL suggested for Pharmaceuticals and Biotechnology - value screen: https://zpr.io/NGP6QnBCdEbN

User Image BjornHernandez1 Posted - 1 day ago

🔥 LabConnect: Central lab for clinical trials—big potential clients. 🌍 Genova Diagnostics: 50+ countries, serving healthcare pros globally. 🔬 ACM Global: Central lab player for clinical trials—big reach. 🏥 ARUP: Trusted by U.S. hospitals and clinics nationwide. 🩺 Mayo Clinic Labs: Partners with 4,000+ global healthcare orgs. 💡 Quest Diagnostics: Serves ~50% of U.S. hospitals & doctors. 🌐 Labcorp: Massive global network in 100+ countries. 🔗 OPKO/BioReference: Multinational lab powerhouse. 📊 Sonic Healthcare: Global diagnostics + radiology leader. ⚡ BioReference: 12M+ tests/year across U.S. facilities. 🚀 TMO is already on board ($210B market cap)—who’s next? LET’S GOOO! 💥 $MIRM $SUPN $HRMY

User Image MckinleyCarr Posted - 2 days ago

😏🚀 MYNZ We know the date of the reverse split (RS) if there will be one, but possibly a Nasdaq extension will be granted. Last time it traded, 50 million and 19 million heavy shorts attacked. Now, it has huge credibility after the TMO partnership and the meeting. The company will decide by November 25th whether or not to do an RS based on Nasdaq's response. Anyway, after the RS, I'm not worried about what happens next. A $210 billion partner TMO signing a deal with a penny stock has never happened before. I will be loading heavy on Monday. This will go to the moon like the DRUG stock recently did. The price target (PT) is $50. The squeeze will be parabolic. $SUPN $HRMY

User Image UncleStock Posted - 1 week ago

$SIGA $SMLR $HRMY $INVA suggested for Health Care - value screen: https://zpr.io/w3j8HS7Eft4n

User Image MoniBarnett Posted - 1 week ago

MYNZ 🔥 Perfect time to jump in, cheapest dip!!! Shorts volume increased. Low Float only 29M outstanding shares. Any buy-in will make this fly to the moon. Here is why… 1.Frankie Muniz backing Mainz (yes, the Malcolm guy & NASCAR #33 now repping MYNZ). 2.Petra, ex-Obama advisor, hinted at a big U.S. lab partner. Solid source! 3.Six news hits in 3 weeks—momentum. 4.Already solid in the EU, not new but expanding, with insurance covering their tests. 5.Their test has 88% accuracy vs. EXAS (42%) & GH (20%)—big edge! 6.$1.5M private placement in the bag. 7.CEO teased big plans ahead. 8.Offering Deal $SUPN $HRMY

User Image UncleStock Posted - 1 week ago

$HRMY $CPRX $REGN suggested for #raremetals - value screen: https://zpr.io/g2sfw

User Image Alice_McL Posted - 2 weeks ago

🚨 MYNZ HUGE PR drop incoming before the Nov 13 meeting 🔥 Someone is pushing these dates of upcoming NEWS 3 biggest stock alert channels announced, might consider to add now, who knows. $SUPN $HRMY

User Image UncleStock Posted - 2 weeks ago

$SITC $LPG $AMR $HRMY suggested for $SML US S&P Small-Cap 600 Index - value screen: https://zpr.io/tQPv2

User Image BourlaBeliever Posted - 2 weeks ago

$HRMY Will this go back to $35?

User Image IN0V8 Posted - 2 weeks ago

$HRMY https://theenterpriseleader.com/2024/10/30/oppenheimer-reiterates-outperform-rating-for-harmony-biosciences-nasdaqhrmy.html

User Image IN0V8 Posted - 2 weeks ago

$HRMY Oct 30 (Reuters) - Harmony Biosciences Holdings Inc : * HARMONY BIOSCIENCES HOLDINGS, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK BY SELLING SHAREHOLDERS * HARMONY BIOSCIENCES HOLDINGS INC - PRICES PUBLIC OFFERING OF 8 MILLION SHARES AT $31 EACH

User Image IN0V8 Posted - 2 weeks ago

$HRMY bought at $31.88

User Image insiderbuyingselling Posted - 10/31/24

$HRMY new insider selling: 21496 shares. http://insiderbuyingselling.com/?t=HRMY

User Image knowthyself Posted - 10/31/24

$HRMY $31? Thieves!

User Image 50bps Posted - 10/31/24

$HRMY fuckers should have just dribbled their shares into the open market over the last year. serves em right

User Image DonCorleone77 Posted - 10/31/24

$HRMY Harmony Biosciences 8M share Secondary priced at $31.00 JPMorgan acted as sole book running manager for the offering.

User Image Shlobby Posted - 10/30/24

Last 2 candles looknlike ying and yang def not in $HRMY

User Image knowthyself Posted - 10/30/24

$HRMY Guess on pricing of offering?

User Image WhosYourDaddy_ Posted - 10/30/24

$HRMY Your old CEO JJ is coming back..you can have his FRAUD ass $NVAX

User Image PfizeredUp Posted - 10/30/24

$HRMY what’s going on?

User Image IN0V8 Posted - 10/30/24

$HRMY Opportunity Oppenheimer raises target price to $59 from $56

User Image BrightInvestor Posted - 10/30/24

$HRMY just wondering how ZYN002 (cannabidiol gel) phase 3 is going? As a Zynerba stock ex-holder I would like to know if we are going to get anything back from it?

User Image TAFox Posted - 10/30/24

$HRMY wow. All gains from yesterday’s earnings evaporated.

User Image 50bps Posted - 10/30/24

$HRMY

User Image OpenOutcrier Posted - 10/30/24

$HRMY (-7.2% pre) Harmony Biosciences (HRMY) Commences 8M Share Offering by Selling Stockholders - SI https://ooc.bz/l/46309

User Image Idvst8 Posted - 10/29/24

$HRMY - Good one on dips

User Image jParkz Posted - 10/29/24

News Article $HRMY Harmony Biosciences (HRMY) Q3 2024 Earnings Call Transcript https://marketwirenews.com/news-releases/harmony-biosciences-hrmy-q3-2024-earnings-call-trans-6183549406563737.html $HRMY

User Image jParkz Posted - 10/29/24

$HRMY News out HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS https://marketwirenews.com/news-releases/harmony-biosciences-reports-strong-third-quarter-202-5648045385231267.html $HRMY

User Image Doozio Posted - 10/29/24

If yo can’t $hear a 🧠👀 became da FUTUre of 🧠⏰ n whUt stonks do once $xbi $iwm join in $hrmy NOW during 🧠⏰♾️

User Image 50bps Posted - 10/29/24

$HRMY 🔥

Analyst Ratings
Needham Buy Oct 2, 24
Needham Buy Sep 24, 24
Needham Buy Sep 12, 24
UBS Buy Sep 10, 24
Needham Buy Aug 8, 24
Needham Buy Aug 6, 24
Needham Buy Jun 25, 24
Needham Buy Jun 24, 24
Citigroup Buy Jun 21, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Nielsen Jack Director Director Dec 14 Sell 59.96 2,834 169,927 2,571,024 12/16/22
Wicki Andreas Director Director Dec 12 Sell 60.16 28,841 1,735,075 2,147,943 12/14/22
Nielsen Jack Director Director Dec 07 Sell 60.05 110,751 6,650,598 2,573,858 12/09/22
Nielsen Jack Director Director Dec 07 Sell 60.05 110,751 6,650,598 2,573,858 12/09/22
Wicki Andreas Director Director Dec 05 Sell 61.23 77,853 4,766,939 2,176,784 12/07/22
Nielsen Jack Director Director Nov 29 Sell 58.92 129,652 7,639,096 2,684,609 12/01/22
Nielsen Jack Director Director Nov 18 Sell 57.23 77,600 4,441,048 2,814,261 11/22/22
Wicki Andreas Director Director Nov 14 Sell 59.6 51,278 3,056,169 2,254,637 11/16/22
Nielsen Jack Director Director Nov 11 Sell 57.55 158,400 9,115,920 2,891,861 11/15/22
Wicki Andreas Director Director Nov 08 Sell 58.95 129,408 7,628,602 2,305,915 11/10/22
Wicki Andreas Director Director Nov 02 Sell 59.02 576,767 34,040,788 2,435,323 11/04/22
Dayno Jeffrey M. CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Nov 01 Option 8.22 15,000 123,300 15,000 11/02/22
Dayno Jeffrey M. CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Nov 01 Sell 55.1 15,000 826,500 11/02/22
Wicki Andreas Director Director Aug 08 Sell 53.41 578,552 30,900,462 3,012,090 08/10/22
Nielsen Jack Director Director Aug 04 Sell 52.76 250,000 13,190,000 3,050,261 08/08/22
Wicki Andreas Director Director Aug 03 Sell 52.71 72,586 3,826,008 3,590,642 08/05/22
Nielsen Jack Director Director Jul 18 Sell 55.19 40,087 2,212,402 3,375,378 07/20/22
Nielsen Jack Director Director Jul 13 Sell 55.04 5,773 317,746 3,415,465 07/15/22
Nielsen Jack Director Director Jul 08 Sell 55.04 10,768 592,671 3,421,238 07/12/22
Nielsen Jack Director Director Jul 05 Sell 54.51 300,741 16,393,392 3,432,006 07/07/22
Nielsen Jack Director Director Jun 29 Sell 52.12 14,571 759,441 3,732,747 07/01/22
Nielsen Jack Director Director Jun 24 Sell 52.18 100,463 5,242,159 3,747,318 06/28/22
Nielsen Jack Director Director Apr 21 Sell 52.19 6,554 342,053 3,847,781 04/25/22
Nielsen Jack Director Director Apr 18 Sell 52.21 132,258 6,905,190 3,854,335 04/20/22
Nielsen Jack Director Director Apr 12 Sell 50.9 119,829 6,099,296 3,986,593 04/14/22
Nielsen Jack Director Director Apr 07 Sell 50.17 11,165 560,148 4,093,195 04/11/22
Nielsen Jack Director Director Apr 04 Sell 50.13 21,394 1,072,481 4,102,969 04/06/22
Dierks Jeffrey Chief Commercial Off.. Chief Commercial Officer Apr 01 Option 24 14,471 347,304 14,471 04/05/22
Dierks Jeffrey Chief Commercial Off.. Chief Commercial Officer Apr 01 Sell 49.61 14,471 717,906 04/05/22
Nielsen Jack Director Director Mar 30 Sell 50.13 37,391 1,874,411 4,121,697 04/01/22
Nielsen Jack Director Director Mar 25 Sell 50.65 114,121 5,780,229 4,154,429 03/29/22
Nielsen Jack Director Director Mar 22 Sell 50.17 36,294 1,820,870 4,254,330 03/24/22
Nielsen Jack Director Director Mar 17 Sell 50.08 16,181 810,344 4,286,097 03/21/22
Jacobs John C President, CEO President, CEO Mar 16 Option 8.22 15,000 123,300 15,000 03/18/22
Jacobs John C President, CEO President, CEO Mar 16 Sell 45.32 15,000 679,800 03/18/22
Wicki Andreas Director Director Mar 09 Sell 45.14 285,587 12,891,397 3,663,228 03/11/22
Wicki Andreas Director Director Mar 01 Sell 40.59 596,428 24,209,013 3,948,815 03/04/22
Dierks Jeffrey Chief Commercial Off.. Chief Commercial Officer Feb 16 Option 24 4,459 107,016 200 02/18/22
Dierks Jeffrey Chief Commercial Off.. Chief Commercial Officer Feb 16 Sell 40.03 8,518 340,976 02/18/22
Wicki Andreas Director Director Dec 08 Sell 40.09 27,268 1,093,174 4,545,243 12/10/21
Dayno Jeffrey M. Chief Medical Office.. Chief Medical Officer Oct 19 Option 8.22 18,200 149,604 4,101 10/20/21
Dayno Jeffrey M. Chief Medical Office.. Chief Medical Officer Oct 19 Sell 43.45 18,200 790,790 10/20/21
Dierks Jeffrey Chief Commercial Off.. Chief Commercial Officer Sep 09 Sell 37 5,000 185,000 09/09/21
Dierks Jeffrey Chief Commercial Off.. Chief Commercial Officer Sep 09 Option 8.22 5,000 41,100 5,000 09/09/21
Dayno Jeffrey M. Chief Medical Office.. Chief Medical Officer Sep 09 Sell 37.58 10,000 375,800 09/09/21
Dayno Jeffrey M. Chief Medical Office.. Chief Medical Officer Sep 09 Option 8.22 10,000 82,200 10,000 09/09/21